All articles
ManufacturingJune 2, 2026·Updated July 31, 2026·6 min read

Softgel Stability Mistakes That Kill Launches

Oxidation, leaking shells, and bloom are not bad luck — they are briefing and process failures. How to brief softgel projects so they survive.

Softgel Stability Mistakes That Kill Launches

Softgels look simple: oil in a shell. In practice they are one of the most stability-sensitive formats in dietary supplements — especially for omega oils, botanicals, and moisture-sensitive fills.

The three failure modes we see most

1. Oxidation before the consumer opens the bottle

Unsaturated oils oxidise when oxygen, heat, and light stack up. If your brief never specifies antioxidant strategy, packaging barrier, or nitrogen flush expectations, the first production lot can taste "off" months before expiry.

2. Shell leakage and sticking

Gelatin and HPMC shells behave differently with humidity. Skipping controlled drying or packing warm softgels into bottles creates welded clusters and leakers — both expensive returns.

3. Bloom and appearance rejects

Temperature cycling in shipping creates white bloom that consumers read as "expired." Stability protocols must include distribution-like conditions, not only static lab shelves.

How to brief softgels correctly

  • Name the fill chemistry (fish oil, algae oil, botanical extract carrier).
  • State shell preference (gelatin vs vegetarian) and any enteric need.
  • Define target shelf life and storage claim.
  • Confirm bottle / blister barrier and desiccant expectations.
  • Ask for oxidation and leak checks on the pilot — not only after full PO.

Design stability in from the formula stage

Most softgel stability problems are decided before the first shell is formed. The fill chemistry, the antioxidant package, and the shell material together set the ceiling on shelf life — no amount of downstream drying or packaging can rescue a formula that was always going to oxidise.

For omega oils specifically, oxidation is the dominant failure mode. Polyunsaturated oils react with oxygen, and the reaction accelerates with heat and light. A credible brief specifies the peroxide value target at fill, the tocopherol or rosemary extract used as a carrier antioxidant, and whether the line runs a nitrogen flush to displace headspace oxygen. If none of that is in the brief, the manufacturer is making assumptions — and the first lot is the experiment.

Shell choice matters more than founders expect. Gelatin shells are the default and well-understood, but they are hygroscopic — they absorb moisture and become brittle in dry climates, sticky in humid ones. Vegetarian (HPMC) shells behave differently and can suit certain fills better, but they have their own sealing and drying profile. Enteric coatings add another layer: they resist stomach acid for targeted release, but they also add a coating step that has its own stability and adhesion tests.

Packaging is part of the stability protocol

A softgel that is stable in the lab can still fail in distribution. The bottle, the cap liner, the desiccant, and even the fill volume of the bottle all change how the product ages on a real shelf.

  • Bottle barrier — HDPE is common, but PET and glass have different oxygen transmission rates. For oxidation-sensitive fills, the bottle barrier is not a packaging detail; it is a stability input.
  • Desiccant — gelatin shells need humidity control. The desiccant type and count must match the bottle size and the climate the product will ship through, not just the lab shelf.
  • Fill volume — a half-empty bottle leaves more headspace for oxygen. The fill volume affects oxidation, so it belongs in the stability conversation, not just the cost conversation.

Ask for the right tests on the pilot

A generic potency panel does not catch softgel-specific risks. Ask for:

  • Peroxide value and p-anisidine value for oil fills — these measure oxidation, not just potency.
  • Leak and weld checks — physical integrity of the seam.
  • Disintegration at a real-world timepoint, not only at release.

Accelerated vs real-time: what each actually tells you

Stability data is only useful if you know what it can and cannot predict. Softgel programs typically run two conditions in parallel, and founders should understand the difference rather than accept a single number.

Accelerated stability (40°C / 75% RH for 6 months) is the fast forecast. It is good for an early read on whether a formula is viable, but it over-predicts failure for heat-sensitive actives — a softgel that "fails" accelerated at month three may be perfectly stable at room temperature for two years. Treat accelerated as a screening tool, not a verdict.

Real-time stability (25°C / 60% RH, measured over 12–24 months) is the number that actually goes on the label. It is slower and more expensive, but it is the only data that defends your expiry date against a retailer review or an Amazon compliance request. A manufacturer offering only accelerated data is giving you a projection, not a measurement.

The softgel-specific trap: neither condition fully models distribution. A bottle that sits in a hot shipping container or a warehouse cycling between day and night temperatures ages differently than one on a static lab shelf. Temperature-cycling studies — where the product is moved between conditions to simulate real logistics — catch the bloom and shell-stress failures that static chambers miss. For any softgel that will ship through extreme climates, ask whether the protocol includes distribution-like cycling, not just the two standard conditions.

The cost of finding out late

Softgel stability failures are expensive precisely because they surface late. A potency shortfall found at release is a re-test. An oxidation problem found after the product ships is a recall — and softgel recalls are among the costliest in the category, because the failure (rancidity, leaking, bloom) is visible to the consumer, not just to a lab.

The pattern is the same as every other compliance question in supplements: the cost of asking for the right protocol goes up the later you ask. Asking at the brief costs an email. Asking after the first production run costs a re-validation. Asking after launch costs the SKU.

At HiGO, softgel programs typically start at 300,000–500,000 units as capacity scales. We would rather sequence your timeline honestly than rush a shell that fails in the field.

If softgels are your hero SKU: book a technical call early — shell and fill decisions lock most of your timeline.

Our Author

Daniel Brooks, Manufacturing Operations Editor

Daniel Brooks

Manufacturing Operations Editor

Daniel focuses on production transfer, equipment fit, process controls, scale-up, packaging operations, and the scheduling decisions that move a supplement from approval to finished goods.

Building a supplement brand?

Tell us about your project — format, volume, timeline — and get a tailored quote within 24 hours.

Get a Quote

Manufacturing you can verify

FDA-registered, cGMP-certified and SQF-registered production in Ontario, California - documentation packs ready for your retail and marketplace onboarding.

FDA Registered FacilityFDA Registered Facility
cGMP Certified FacilitycGMP Certified Facility
HACCP / GMP CertifiedHACCP / GMP Certified
Non-GMONon-GMO
Made in USAMade in USA
SQF RegisteredSQF Registered

Ready to build your next formula?

Get a tailored manufacturing quote within 24 hours — format, volume, and timeline.

Get a Quote
HiGO Biotech

Tell us about your project

Share the essentials and our manufacturing team will reply with next steps within 24 hours.

Response within 24 hoursDetails used only for your quote